MMDA-3a

In this article we will explore in depth the topic of MMDA-3a, a topic of great relevance today. MMDA-3a is a concept that has sparked great interest and debate in various areas, generating conflicting opinions and divergent perspectives. In this sense, it is crucial to analyze in detail all aspects related to MMDA-3a, in order to understand its true scope and impact. Throughout this article, we will address different approaches, research and points of view that will allow the reader to obtain a comprehensive view of MMDA-3a. Furthermore, we will examine its evolution over time, as well as its influence in various contexts and situations. By presenting data, analysis and reflections, we aim to offer a complete and updated perspective on MMDA-3a, in order to contribute to the debate and increase knowledge around this very relevant topic.

MMDA-3a
Clinical data
Other names2-Methoxy-3,4-methylenedioxyamphetamine; 2-Methoxy-MDA; 2-MeO-MDA
Drug classSerotonergic psychedelic; Hallucinogen
Identifiers
  • 1-(4-methoxy-1,3-benzodioxol-5-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H15NO3
Molar mass209.245 g·mol−1
3D model (JSmol)
  • CC(CC1=C(C2=C(C=C1)OCO2)OC)N
  • InChI=1S/C11H15NO3/c1-7(12)5-8-3-4-9-11(10(8)13-2)15-6-14-9/h3-4,7H,5-6,12H2,1-2H3
  • Key:OSJXZWMDUMAITM-UHFFFAOYSA-N

MMDA-3a, also known as 2-methoxy-3,4-methylenedioxyamphetamine or as 2-methoxy-MDA, is a psychedelic drug of the amphetamine family.[1][2] It is the 2-methoxy derivative of 3,4-methylenedioxyamphetamine (MDA).[1] The drug produces hallucinogenic effects in humans.[1] Its dosage is listed as 20 to 80 mg and its duration as 10 to 16 hours in PiHKAL.[1][2] A higher dose of 100 mg was also reportedly explored and doses of 80 to 100 mg were said to be very similar to 100 μg LSD.[1] MMDA-3a is a positional isomer of MMDA and hence is a Schedule I controlled substance in the United States.[2]

See also

References

  1. ^ a b c d e Alexander T. Shulgin; Ann Shulgin (1991). "#134 MMDA-3a 2-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE". PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. pp. 795–798. ISBN 978-0-9630096-0-9. OCLC 25627628.
  2. ^ a b c Shulgin A, Manning T, Daley PF (2011). "#99. MMDA-3a". The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press. pp. 240–241. ISBN 978-0-9630096-3-0. OCLC 709667010.